Aneuploidy Rates in Advanced Maternal Age Patients Supplemented With Coenzyme Q10 (CoQ10) Versus Those That Are Not: a Pilot Study
Launched by REPRODUCTIVE ENDOCRINOLOGY ASSOCIATES OF CHARLOTTE · Apr 17, 2014
Trial Information
Current as of June 01, 2025
Completed
Keywords
ClinConnect Summary
Brief Summary
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. 36-42 years old
- • 2. Must present with an AMH level ≤2.0 ng/mL
- • 3. 1st cycle of IVF treatment
- • 4. Antral follicle count \>5 and \<20
- Exclusion Criteria:
- • 1. BMI \>39
- • 2. Active smoker
- • 3. Blood serum baseline level of CoQ10 ≥2.20 µg/mL
- • 4. Prior use of CoQ10
- • 5. Type II diabetes mellitus
About Reproductive Endocrinology Associates Of Charlotte
Reproductive Endocrinology Associates of Charlotte (REACH) is a leading fertility clinic dedicated to providing advanced reproductive care and innovative treatment options for individuals and couples facing infertility challenges. With a team of highly skilled reproductive endocrinologists and a patient-centered approach, REACH employs cutting-edge technologies and evidence-based practices to enhance the chances of successful conception. Committed to clinical research and excellence in reproductive health, REACH actively participates in clinical trials aimed at improving treatment outcomes and advancing the field of reproductive endocrinology. Their mission is to empower patients with comprehensive care and support throughout their fertility journey.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Charlotte, North Carolina, United States
Patients applied
Trial Officials
Jack L Crain, MD
Principal Investigator
Reproductive Endocrinology Associates of Charlotte
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials